During an exclusive interview to Top Team, the Alanac CEO, Carlos Geyer, reveals that the national industries increased their market share and states that they have faced some difficulties due to the lack of target-oriented criteria by Anvisa and CMED. Click on it and check it out.
Novo Nordisk has new manager
Aché introduces Law director
pharmexx Brasil hires IBD
Avon promotes Silvana Cassol
Hospital Santa Marina reformulates directorate
Do you know anything about net think? Click here abd find out a new concept presented by the founder of the Latin American Institute of Creativity and Strategy